Rotigotine is a non-ergoline dopamine agonist that exerts its therapeutic effects by activating dopamine receptors, primarily indicated for the treatment of Parkinson’s disease and restless legs syndrome.… Read more


















































Rotigotine is a non-ergoline dopamine agonist that exerts its therapeutic effects by activating dopamine receptors, primarily indicated for the treatment of Parkinson’s disease and restless legs syndrome. To support the rigorous analytical demands of pharmaceutical research and manufacturing, this category offers a comprehensive range of rotigotine reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for effective impurity profiling, the development and validation of analytical methods, and the systematic quality control of the active pharmaceutical ingredient. Stable isotope-labelled variants, in particular, provide critical internal standards for mass spectrometry-based quantification, ensuring precision and reliability in complex analytical matrices. By providing these specialized reference materials, the catalogue facilitates consistent adherence to global regulatory guidelines and supports the ongoing evaluation of drug substance stability, purity, and safety throughout the entire pharmaceutical product lifecycle.